Zoetis | ZTS - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
AbbVie USD 645M 69M 2026-03
Align Technology USD 6.93M 9.11M 2026-03
Bayer EUR 675M 87M 2025-12
Bristol-Myers Squibb USD 407M 4M 2026-06
Charles River Laboratories USD 30.34M 3.6M 2026-06
Coherus Biosciences USD 2.25M 76K 2025-12
Dentsply International USD 22M 2M 2026-06
Eli Lilly USD 114.7M 134.3M 2025-09
Henry Schein USD 43M 4M 2026-06
Idexx Laboratories USD 10.18M 2.44M 2026-06
Illumina USD 24M 2M 2026-03
IQVIA Holdings USD 197M 5M 2026-06
J&J USD 43M 25M 2026-03
Laboratory Of America USD 61.1M 6M 2026-06
Merck USD 525M 46M 2026-06
Neogen USD 13.9M 356K 2025-12
Pacira USD 3.62M 77K 2026-06
Perrigo USD 7.61B 373.8M 2026-06
Pfizer USD 667M 4M 2026-06
Phibro Animal Health USD 11.91M 191K 2025-12
Quest Diagnostics USD 69M 2M 2025-09
Sanofi EUR 287M 109M 2026-06
Sanofi EUR -25M 99.78M 2025-12
Zoetis USD 61M 1000K 2026-06